Health Discovery Corporation Applies For U.S. And Foreign Patent Protection Of Prostate Disease Biomarkers Identified Using SVM Technology

SAVANNAH, Ga.--(BUSINESS WIRE)--Nov. 30, 2005--Health Discovery Corporation (“HDC”) announced today that it has filed patent applications in the United States Patent and Trademark Office and in the U.S. Receiving Office for the Patent Cooperation Treaty for U.S. and foreign patent protection of biomarkers for diagnosis, treatment and monitoring of prostate disease. The patent claims cover multiple genetic sequences that were identified using HDC’s patented support vector machine (SVM)-based technology as having the greatest significance for reliably distinguishing among different types of prostate disease as well as for separating diseased prostate from normal tissue.